H, H., Y, Y., X, D., Z, H., Y, C., Z, W., . . . T, L. (2023). Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). International journal of oncology, 63(2), . https://doi.org/10.3892/ijo.2023.5545
Chicago Style (17th ed.) CitationH, Huang, Yao Y, Deng X, Huang Z, Chen Y, Wang Z, Hong H, and Lin T. "Immunotherapy for Nasopharyngeal Carcinoma: Current Status and Prospects (Review)." International Journal of Oncology 63, no. 2 (2023). https://doi.org/10.3892/ijo.2023.5545.
MLA (9th ed.) CitationH, Huang, et al. "Immunotherapy for Nasopharyngeal Carcinoma: Current Status and Prospects (Review)." International Journal of Oncology, vol. 63, no. 2, 2023, https://doi.org/10.3892/ijo.2023.5545.
Warning: These citations may not always be 100% accurate.